← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

# Name Holding Trade Value Theme
Stocks
% of
Portfolio
Status
1876
WCM
Wealthcare Capital Management
Virginia
$8K +$7.65K 1 0% New
1877
CIM
Contravisory Investment Management
Massachusetts
$7K +$6.51K 1 0% New
1878
HDIM
Hanson & Doremus Investment Management
Vermont
$7K $0 1 0% Maintained
1879
MIM
Macroview Investment Management
Maryland
$7K $0 2 0.01% Maintained
1880
DA
Denali Advisors
California
$3K $0 1 0% Maintained
1881
CFA
Camarda Financial Advisors
Florida
$2K -$46K 1 0% Reduced
1882
CA
CapWealth Advisors
Tennessee
$2K $0 1 0% Maintained
1883
CP
Corbenic Partners
Pennsylvania
$1K $0 1 0% Maintained
1884
SAM
Solaris Asset Management
New York
$1K $0 1 0% Maintained
1885
ACM
Accipiter Capital Management
Florida
$0 -$452K 0 – Closed
1886
AR
Advisory Research
Illinois
$0 -$334K 0 – Closed
1887
AO
Allen Operations
New York
$0 -$262K 0 – Closed
1888
AC
Axon Capital
New York
$0 -$20.2M 0 – Closed
1889
Bailard
Bailard
California
$0 -$2.05M 0 – Closed
1890
BA
Broadview Advisors
Wisconsin
$0 -$12.4M 0 – Closed
1891
Burgundy Asset Management
Burgundy Asset Management
Ontario, Canada
$0 -$685K 0 – Closed
1892
CCM
Cadence Capital Management
Massachusetts
$0 -$13.7M 0 – Closed
1893
CCM
Coe Capital Management
Illinois
$0 -$1.31M 0 – Closed
1894
CA
Corrado Advisors
New Jersey
$0 -$400K 0 – Closed
1895
Corvex Management
Corvex Management
New York
$0 -$422M 0 – Closed
1896
CPA
Cowen Prime Advisors
New York
$0 -$300K 0 – Closed
1897
CII
CR Intrinsic Investors
Connecticut
$0 -$38.4M 0 – Closed
1898
CAS
CTC Alternative Strategies
Illinois
$0 -$336K 0 – Closed
1899
DePrince Race & Zollo Inc (DRZ)
DePrince Race & Zollo Inc (DRZ)
Florida
$0 -$33M 0 – Closed
1900
DCC
Dow Chemical Company
Michigan
$0 -$230K 0 – Closed